Intraperitoneal chemotherapy in the management of malignant disease (Q34734279)

4 August 2017

1 reference

title

Intraperitoneal chemotherapy in the management of malignant disease (English)

1 reference

4 August 2017

1 reference

Markman M

1

1 reference

PubMed ID

12113122

4 August 2017

language of work or name

1 reference

1 June 2001

1 reference

Expert Review of Anticancer Therapy

4 August 2017

1 reference

4 August 2017

1

1 reference

4 August 2017

1

1 reference

4 August 2017

142-148

1 reference

Intraperitoneal therapy for treatment of malignant disease principally confined to the peritoneal cavity

4 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.1.142

Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.1.142

Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: Lessons learned from a gynecologic oncology group phase II trial of ip cisplatin and recombinant α-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.1.142

Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.1.142

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.1.142

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.1.142

21 January 2018

Identifiers

DOI

10.1586/14737140.1.1.142

1 reference

4 August 2017

1 reference

PubMed ID

12113122